These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15687926)

  • 1. [Anterior uveitis and topical brimonidine: a case report].
    Velasque L; Ducousso F; Pernod L; Vignal R; Deral V
    J Fr Ophtalmol; 2004 Dec; 27(10):1150-2. PubMed ID: 15687926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior uveitis as a side effect of topical brimonidine.
    Byles DB; Frith P; Salmon JF
    Am J Ophthalmol; 2000 Sep; 130(3):287-91. PubMed ID: 11020406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brimonidine-induced anterior uveitis and conjunctivitis: clinical and histologic features.
    Nguyen EV; Azar D; Papalkar D; McCluskey P
    J Glaucoma; 2008; 17(1):40-2. PubMed ID: 18303383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brimonidine Induced Anterior Uveitis.
    Beltz J; Zamir E
    Ocul Immunol Inflamm; 2016; 24(2):128-33. PubMed ID: 26399160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertensive acute granulomatous anterior uveitis as a side effect of topical brimonidine.
    Clemente-Tomás R; Arciniegas-Perasso CA; Hervás-Hernandis JM; García-Ibor F; Ruiz-Del Río N; Duch-Samper AM
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Oct; 93(10):511-514. PubMed ID: 29910082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brimonidine-associated uveitis - a descriptive case series.
    Hopf S; Mercieca K; Pfeiffer N; Prokosch-Willing V
    BMC Ophthalmol; 2020 Dec; 20(1):489. PubMed ID: 33334316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A paradoxical ocular effect of brimonidine.
    Mushtaq B; Sardar J; Matthews TD
    Am J Ophthalmol; 2003 Jan; 135(1):102-3. PubMed ID: 12504711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate.
    Becker HI; Walton RC; Diamant JI; Zegans ME
    Arch Ophthalmol; 2004 Jul; 122(7):1063-6. PubMed ID: 15249377
    [No Abstract]   [Full Text] [Related]  

  • 9. Brimonidine-timolol fixed combination induced granulomatous inflammation of the eye.
    Carrasco MA; Schlaen BA; Zárate JO
    Int Ophthalmol; 2013 Oct; 33(5):557-60. PubMed ID: 23224363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suspected granulomatous anterior uveitis associated with brimonidine tartrate 0.2% and timolol maleate 0.5% ophthalmic solution.
    Casado A; Cabarga C; de la Fuente MA; Muñoz-Negrete FJ
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2659-60. PubMed ID: 23835755
    [No Abstract]   [Full Text] [Related]  

  • 11. Demographic and clinical factors associated with development of brimonidine tartrate 0.2%-induced ocular allergy.
    Manni G; Centofanti M; Sacchetti M; Oddone F; Bonini S; Parravano M; Bucci MG
    J Glaucoma; 2004 Apr; 13(2):163-7. PubMed ID: 15097264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent central nervous system depression in infants after the use of topical brimonidine.
    Carlsen JO; Zabriskie NA; Kwon YH; Barbe ME; Scott WE
    Am J Ophthalmol; 1999 Aug; 128(2):255-6. PubMed ID: 10458196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulomatous anterior uveitis associated with 0.2% topical brimonidine.
    Cates CA; Jeffrey MN
    Eye (Lond); 2003 Jul; 17(5):670-1. PubMed ID: 12855989
    [No Abstract]   [Full Text] [Related]  

  • 14. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.
    Schuman JS; Horwitz B; Choplin NT; David R; Albracht D; Chen K
    Arch Ophthalmol; 1997 Jul; 115(7):847-52. PubMed ID: 9230823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible cicatricial ectropion precipitated by topical brimonidine eye drops.
    Aristodemou P; Baer R
    Ophthalmic Plast Reconstr Surg; 2008; 24(1):57-8. PubMed ID: 18209648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of brimonidine allergy in patients previously allergic to apraclonidine.
    Williams GC; Orengo-Nania S; Gross RL
    J Glaucoma; 2000 Jun; 9(3):235-8. PubMed ID: 10877374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.
    LeBlanc RP
    Ophthalmology; 1998 Oct; 105(10):1960-7. PubMed ID: 9787370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers.
    Mungan NK; Wilson TW; Nischal KK; Koren G; Levin AV
    J AAPOS; 2003 Feb; 7(1):69-70. PubMed ID: 12690374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed hypersensitivity to brimonidine tartrate 0.2% associated with high intraocular pressure.
    Watts P; Hawksworth N
    Eye (Lond); 2002 Mar; 16(2):132-5. PubMed ID: 11988811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brimonidine and acute anterior granulomatous uveitis: A case report and literature review].
    Comet A; Donnadieu B; Courjaret JC; Gascon P; Denis D; Matonti F
    J Fr Ophtalmol; 2017 Apr; 40(4):e127-e129. PubMed ID: 28336279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.